SEC / FDA / FTC Regulatory Watch Content Archive
15 posts · Page 1 of 1
- SEC/FDA/FTC Regulatory Watch — Week of May 19–27, 2026
- SEC/FDA/FTC Regulatory Watch — Week of May 28–June 1, 2026
- SEC/FDA/FTC Regulatory Watch — Week of June 2–8, 2026
- SEC/FDA/FTC Regulatory Watch — Week of June 9–15, 2026
- SEC, FDA and FTC Watch: Swap-market comments, drug access moves, and merger remedies
- SEC/FDA/FTC Regulatory Watch — Week of June 23–29, 2026
- SEC/FDA/FTC Regulatory Watch — Week of June 30-July 6, 2026
- SEC/FDA/FTC Regulatory Watch: E-Delivery, oral PCSK9 approval, and HSR penalties (July 13-19, 2026)
- SEC/FDA/FTC Regulatory Watch: 24-hour trading, food-color rules, and consumer remedies (July 20–26, 2026)
- SEC's $152M investor case, FDA's freeze-dried plasma, and FTC's health-data suit (July 27–August 2, 2026)
- SEC accounting unit, FDA's three product actions, and FTC's disparate-impact policy (August 3-9, 2026)
- SEC fraud docket, FDA animal-drug EUA, and FTC consumer redress (August 10-16, 2026)
- Crypto rulebook, Genglycos, and FTC pricing scrutiny — August 17–23, 2026
- SEC false adviser filings, FDA approvals, and FTC final orders - August 24-30, 2026
- SEC subpoenas, FDA approvals, and FTC pricing deadline — September 1–7, 2026